Home » Topics » BioWorld Science

BioWorld Science
RSS

Kronos Bio synthesizes new PROTAC CDK9 degradation inducers

June 2, 2022

New MAP4K 1inhibitors identified at Merck & Co.

June 2, 2022

Researchers present novel Hermansky-Pudlak syndrome murine model

June 2, 2022

Expanded collaboration research on COVID-19 protease inhibitors

June 2, 2022

Almac Discovery selects peptide-drug conjugate ADP-c389 for preclinical development

June 2, 2022

SRSF9 overexpression correlates with CRC lymph node metastasis and Dukes stage

June 1, 2022

Olverembatinib, ponatinib identified as possible treatments for COVID-related cytokine storm

June 1, 2022

Close look illuminates ketamine's (relative) staying power

June 1, 2022

Cat model of Rdh5-associated retinopathy mimics the human phenotype

June 1, 2022

Anti-NOTCH3 treatment reverses experimental pulmonary arterial hypertension

June 1, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...